OLVIG
SANA icon

Oliver Lagore Vanvalin Investment Group’s Sana Biotechnology SANA Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-375
Closed -$3.75K – 803
2024
Q1 		$3.75K Buy
+375
New +$2.81K ﹤0.01% 550

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's SANA Position: Q2 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 375 shares — an estimated $3.75K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in SANA in Q1 2024 and held it in 1 quarter. The position peaked at $3.75K in Q1 2024. 147 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 375 Sana Biotechnology shares in Q2 2024, an estimated $3.75K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Sana Biotechnology in Q1 2024 and held it in 1 quarter.
  • Oliver Lagore Vanvalin Investment Group's Sana Biotechnology position peaked at $3.75K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2024, filed 15 Aug 2024.